Oncotelic Therapeutics, Inc. (OTLC) stock
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Earnings
Oncotelic Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Oncotelic Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2021ended Sep 30, 2021 | Nov 24, 2021after the close | – | – | $0.00 | Release |
| Q3 FY2015ended Sep 30, 2015 | Nov 10, 2015after the close | – | – | – | Filing |
| Q2 FY2015ended Jun 30, 2015 | Aug 4, 2015after the close | – | – | – | Filing |
| Q1 FY2015ended Mar 31, 2015 | Apr 30, 2015after the close | – | – | – | Filing |
| Q4 FY2014ended Dec 31, 2014 | Mar 17, 2015after the close | – | – | – | Filing |
| Q3 FY2014ended Sep 30, 2014 | Nov 12, 2014after the close | – | – | – | Filing |
| Q2 FY2014ended Jun 30, 2014 | Aug 5, 2014after the close | – | – | – | Filing |
| Q1 FY2014ended Mar 31, 2014 | May 6, 2014after the close | – | – | – | Filing |
| Q4 FY2013ended Dec 31, 2013 | Mar 18, 2014after the close | – | – | – | Filing |
| Q3 FY2013ended Sep 30, 2013 | Nov 12, 2013after the close | – | – | – | Filing |
| Q2 FY2013ended Jun 30, 2013 | Aug 6, 2013after the close | – | – | – | Filing |
| Q1 FY2013ended Mar 31, 2013 | Apr 9, 2013after the close | – | – | – | Filing |
| Q4 FY2012ended Dec 31, 2012 | Mar 12, 2013after the close | – | – | – | Filing |
| Q3 FY2012ended Sep 30, 2012 | Oct 4, 2012after the close | – | – | – | Filing |
| Q1 FY2012ended Mar 31, 2012 | May 9, 2012after the close | – | – | – | Filing |
| Q4 FY2011ended Dec 31, 2011 | Mar 13, 2012after the close | – | – | – | Filing |
| Q3 FY2011ended Sep 30, 2011 | Nov 9, 2011after the close | – | – | – | Filing |
| Q2 FY2011ended Jun 30, 2011 | Jul 8, 2011after the close | – | – | – | Filing |
| Q1 FY2011ended Mar 31, 2011 | May 12, 2011after the close | – | – | – | Filing |
| Q4 FY2010ended Dec 31, 2010 | Mar 3, 2011after the close | – | – | – | Filing |
| Q3 FY2010ended Sep 30, 2010 | Nov 4, 2010during market hours | – | – | – | Filing |
| Q2 FY2010ended Jun 30, 2010 | Aug 13, 2010before the open | – | – | – | Filing |
| Q4 FY2009ended Dec 31, 2009 | Feb 25, 2010after the close | – | – | – | Filing |
| Q4 FY2008ended Dec 31, 2008 | Feb 26, 2009after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Oncotelic Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Oncotelic Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Oncotelic Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- Update
See a number that looks wrong?